Sofinnova Investments, Inc. Vera Therapeutics, Inc. Transaction History
Sofinnova Investments, Inc.
- $1.06 Billion
- Q3 2024
A detailed history of Sofinnova Investments, Inc. transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, Sofinnova Investments, Inc. holds 2,793,987 shares of VERA stock, worth $119 Million. This represents 11.68% of its overall portfolio holdings.
Number of Shares
2,793,987
Previous 2,793,987
-0.0%
Holding current value
$119 Million
Previous $101 Million
22.14%
% of portfolio
11.68%
Previous 5.61%
Shares
5 transactions
Others Institutions Holding VERA
# of Institutions
184Shares Held
55.1MCall Options Held
134KPut Options Held
156K-
Avoro Capital Advisors LLC New York, NY4.31MShares$184 Million2.87% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.94MShares$168 Million0.02% of portfolio
-
Black Rock Inc. New York, NY3.34MShares$142 Million0.0% of portfolio
-
Abingworth LLP London, X02.96MShares$126 Million19.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.58MShares$110 Million0.0% of portfolio
About Vera Therapeutics, Inc.
- Ticker VERA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,042,300
- Market Cap $1.15B
- Description
- Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...